Elliot Maza is a life science entrepreneur and senior adviser with decades of experience guiding pharmaceutical and med-tech companies. He’s served as CEO, CFO, and Director of several NASDAQ and OTC-listed biotech firms, providing expertise in corporate growth, investor relations, M&A, and licensing.

Earlier in his career, Elliot was a partner at Ernst & Young, and held roles at Sullivan & Cromwell, Goldman Sachs, and J.P. Morgan. A licensed attorney and CPA (inactive), Elliot shares insights on building, financing, and scaling innovative healthcare companies.